| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA879007 | F | In vitro cytotoxicity against MDA 468 human breast cancer cell line with ER negative EGFR positive | Homo sapiens | 1 | ALA1129614 | cell-based format | Scientific Literature | |
| 2. | ALA707776 | F | In vitro inhibitory activity against mammary carcinoma MDA 468 cell lines | Homo sapiens | 29 | ALA1129614 | cell-based format | Scientific Literature | |
| 3. | ALA709418 | F | Inhibitory activity against MDA-468 cell line using MTT assay (ER-, amplified EGFR, mutant p53) | Homo sapiens | 12 | ALA1133721 | cell-based format | Scientific Literature | |
| 4. | ALA873358 | F | In vitro cytotoxic activity against human breast cancer cell line MD-MB-468 after 72 hr of drug exposure determined by the SRB assay | Homo sapiens | 10 | ALA1137951 | cell-based format | Scientific Literature | |
| 5. | ALA710678 | F | Inhibitory activity of compound against breast cancer cell line MDA 468, following 72 hr treatment | Homo sapiens | 12 | ALA1136555 | cell-based format | Scientific Literature | |
| 6. | ALA710679 | F | Inhibitory activity of compound against breast cancer cell line MDA 468, following 72 hr treatment | Homo sapiens | 1 | ALA1136555 | cell-based format | Scientific Literature | |
| 7. | ALA710680 | F | In vitro antitumor activity against MDA-468 carcinoma cell line. | Homo sapiens | 26 | ALA1132564 | cell-based format | Scientific Literature | |
| 8. | ALA713292 | F | Inhibition of MDA-MB-468 cell proliferation | Homo sapiens | 2 | ALA1127418 | cell-based format | Scientific Literature | |
| 9. | ALA713293 | F | Inhibition of MDA-MB-468 cell proliferation at 0.5E-6M; Inhibitory activity | Homo sapiens | 1 | ALA1148284 | cell-based format | Scientific Literature | |
| 10. | ALA713294 | F | Percentage viability of compound against MDA-MB-468 cell line; 92-94% | Homo sapiens | 1 | ALA1148455 | cell-based format | Scientific Literature | |
| 11. | ALA713295 | F | Percentage viability of compound against MDA-MB-468 cell line; NE means No effect | Homo sapiens | 1 | ALA1148455 | cell-based format | Scientific Literature | |
| 12. | ALA713296 | F | Cytotoxic effect on breast cancer cell line MDA-MB-468 | Homo sapiens | 1 | ALA1128390 | cell-based format | Scientific Literature | |
| 13. | ALA713357 | F | The compound was tested in vitro for its antitumor activity against human breast cell line MDA-468 | Homo sapiens | 9 | ALA1133153 | cell-based format | Scientific Literature | |
| 14. | ALA872682 | F | Inhibition of MDA-468 human breast tumor cell proliferation | Homo sapiens | 3 | ALA1133720 | cell-based format | Scientific Literature | |
| 15. | ALA713358 | F | Inhibitory activity against MDA-468 mammary carcinoma cell line | Homo sapiens | 7 | ALA1145965 | cell-based format | Scientific Literature | |
| 16. | ALA713359 | F | Inhibitory activity against MDA-468 mammary carcinoma cell line; not determined | Homo sapiens | 4 | ALA1145965 | cell-based format | Scientific Literature | |
| 17. | ALA713367 | F | Inhibition of MDA-MB468 tumor cell proliferation | Homo sapiens | 11 | ALA1134300 | cell-based format | Scientific Literature | |
| 18. | ALA833510 | F | Inhibitory concentration was measured by the incorporation of [14C]thymidine in (human breast carcinoma) MDA-MB-468 cell line | 4 | ALA1143566 | cell-based format | Scientific Literature | ||
| 19. | ALA827424 | F | In vitro inhibitory concentration was measured by the incorporation of [14C]thymidine in (human breast carcinoma) MDA-MB-468 cell line | 1 | ALA1143566 | cell-based format | Scientific Literature | ||
| 20. | ALA859808 | F | Growth inhibition in human breast cancer MDA-MB-468 cell line using SRB | Homo sapiens | 11 | ALA1148576 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!